Drug Profile
Dithymidine
Latest Information Update: 07 Apr 2000
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Codon Pharmaceuticals [CEASED]; Nonindustrial source
- Class Antineoplastics; Oligodeoxyribonucleotides; Thionucleotides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin cancer
Most Recent Events
- 07 Apr 2000 Discontinued-Preclinical for Skin cancer in USA (Unknown route)
- 09 Sep 1998 Profile reviewed
- 09 Sep 1998 No-Development-Reported for Skin cancer in USA (Unknown route)